Cesar Jorge Tula, M.D.
Hematology & Oncology Physician · Waco, TX
Cesar Jorge Tula, M.D. is a hematology & oncology physician with a practice address in Waco, Texas, and NPI 1487630885, issued on Dec 16, 2005. Check the license (Texas G1788, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Cesar Jorge Tula
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- G1788 TX
DR.0065703 CO
Self-reported in NPPES; status is on the state search - Practice location
- 150 Hillcrest Medical Blvd, Waco, TX 76712
- Phone
- (254) 202-4000
- Enumerated
- Dec 16, 2005
- Record last updated
- May 7, 2025
- Medicaid ID
- 115952705 TX
- Medicare enrollment
- Enrolled (PECOS I20100826001106); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 922 in Texas → Look up another NPI →
Also registered at 150 Hillcrest Medical Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Nnewueze Amaechi, M.DHematology & Oncology Physician1588985717
- Tara Barnett, M.D.Hematology & Oncology Physician1871737106
- Nancy Bednarz, MDRadiation Oncology Physician1346277704
- Miriam Blasingame, NP-CNurse Practitioner1912548249
- Amanda Ibanez, LCSWClinical Social Worker1326569666
- Dominic Nguyen, MDRadiation Oncology Physician1093991341
Verify Cesar Jorge Tula in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license G1788Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
62% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
332 Medicare Part D claims for 75 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 50% of claims.
Most prescribed
- Anastrozole31 claims
- Erleada18 claims
- Erivedge17 claims
- Tamoxifen Citrate17 claims
- Zarxio16 claims
- Dexamethasone15 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $344.47
17 payments; by number, the most common kind was food and beverage; the largest payer was Genzyme Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Cesar Jorge Tula among 922 hematology & oncology physician records in Texas
Cesar Jorge Tula, M.D. is one of 922 hematology & oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2005, is newer than 0% of them.
- NPI issued2005 · 0% of these records are older, 93% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 75% of these records are
- Graduated1970 · median 2004 among the 691 with a school on file
- Record last updated2025 · 51% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Texas
There are 922 hematology & oncology physician records in Texas.
All 922 in Texas → Every provider in Waco → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Nnewueze Amaechi, M.DWaco, TX 767121588985717
- Robert Anderson, M.D.Waco, TX 767121760425706
- Tara Barnett, M.D.Waco, TX 767121871737106
- Thomas Harris, M.D.Waco, TX 767121992789291
- Ofobuike Okani, M.D.Waco, TX 767121821104431
- Baochong Chang, M.D.Waco, TX 767081790851525
- Tyler Snedden, M.D.Waco, TX 767071780002758
- Gerald Edelman, M.D.Killeen, TX 765491831131739
Common questions
What is Cesar Jorge Tula, M.D.'s NPI number?
Cesar Jorge Tula, M.D.'s National Provider Identifier (NPI) is 1487630885, issued on Dec 16, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Cesar Jorge Tula, M.D. located?
The NPPES record lists a practice address at 150 Hillcrest Medical Blvd, Waco, TX, 76712. Phone: (254) 202-4000. Providers update this record themselves, so call before visiting.
How can I verify Cesar Jorge Tula, M.D.'s license?
NPPES lists Texas license number G1788, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Cesar Jorge Tula, M.D. prescribe under Medicare Part D?
In 2024, Cesar Jorge Tula, M.D. had 332 Medicare Part D claims for 75 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.